Recent Advances in Non-Viral Gene Delivery Systems for Hepatic Gene Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Hepatology

Background:

• Gene therapy aims to treat diseases by modifying genetic material.
• Hepatic disorders represent a significant area for gene therapy intervention.
• Traditional viral vectors for gene delivery face safety and immunogenicity challenges.

Purpose of the Study:

• To review recent advancements in non-viral nanocarrier systems for liver-targeted gene delivery.
• To highlight the advantages of nanocarriers over viral vectors in hepatic gene therapy.
• To discuss the design, mechanisms, and challenges of nanocarrier-based hepatic gene delivery.

Main Methods:

• Review of current literature on non-viral nanocarriers for gene delivery.
• Analysis of polymeric nanoparticles, lipid-based nanocarriers, and metal-organic frameworks.
• Examination of studies focusing on gene delivery to the liver using these nanocarriers.

Main Results:

• Non-viral nanocarriers show promise as alternatives to viral vectors for hepatic gene delivery.
• These systems offer improved safety, payload capacity, specificity, and reduced immunogenicity.
• Various nanocarrier platforms have been designed and studied for liver-targeted gene delivery.

Conclusions:

• Non-viral nanocarriers are a rapidly developing field with significant potential for treating liver diseases.
• Further research is needed to optimize nanocarrier design and overcome delivery challenges.
• Nanotechnology offers a promising avenue for advancing gene therapy in hepatology.